butyl[(2,3,4-trimethoxyphenyl)methyl]amine, 95.0%, 10g

4-(4-Bromo-1H-pyrazol-1-yl)-1-methylpiperidine, 95%, 100mg

(7-Chloro-3-methyl-4-oxo-6-((prop-2-ynyl(4-(pyridin-3-ylmethylcarbamoyl)phenyl)amino)methyl)-3,4-dihydroquinazolin-2-yl)methyl acetate, 98%, 25mg

(R)-2-PHENYLBUTANOIC ACID, 95.0%, 1g

Ethyl 2-acetylbenzoate, 97.0%, 1g

3-Bromo-4-methoxy-5-nitro-benzoic acid, 98.0%, 5g

3,4-Dimethylpyrrole, 95.0%, 250mg

3,5-Difluoro-4-methylbenzaldehyde, 97.0%, 5g

Tributyl O-Acetylcitrate>97.0%(GC)500mL

2-aminoquinoline-4-carboxylic acid, 95%, 1g

N-(4-methylphenyl)-2,3-dihydrothiophen-3-amine 1,1-dioxide, 95.0%, 2.5g

NHS C3 azidas, ≥95 %, 5 mg, envase de plástico.

5-Bromo-2-iodopyridine, 98.0%, 5g